Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Functional Imaging Technique Measures Brain Resting State

By HospiMedica International staff writers
Posted on 18 Jan 2016
A new study suggests that functional magnetic resonance imaging (fMRI) could be a cost-effective alternative for estimating relative levels of activity in a cerebral metabolic map.

Researchers at Western University (WU; London, Canada) and the University Hospital of Liège (Belgium) conducted a study to gauge the possibility of using fMRI instead of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for generating the metabolic maps that are used to asses changes in brain activity in clinical applications, such as during the study of severe brain injury and disorders of consciousness. More...


To do so, the researchers first extracted resting state fMRI functional connectivity maps using independent component analysis, and combined only components of neuronal origin. They then compared the generated maps with the FDG-PET maps in 16 healthy controls, 11 vegetative state/unresponsive wakefulness syndrome patients, and in four locked-in patients.

The results showed a significant similarity for healthy controls and for vegetative state/unresponsive wakefulness syndrome patients between the FDG-PET and the fMRI based maps, with conjunction analysis showing decreased frontoparietal and medial regions in vegetative patients with respect to controls. Subsequent analysis in locked-in syndrome patients, which are known to be conscious, also produced consistent neuronal maps with healthy controls. The study was published on December 29, 2015, in Brain and Behavior.

“Many hospitals in developing countries have access to functional MRI technology or FDG-PET, but not both. By developing new fMRI techniques, hospitals that already have the expensive scanning equipment or wish to purchase a unit effectively get 'more bang for their buck’,” said lead author Andrea Soddu, PhD, of the WU department of physics and astronomy. “If no metabolic absolute measures can be extracted, our approach may still be of clinical use in centers without access to FDG-PET.”

PET scans are widely used to diagnose and track a variety of diseases, including cancer, because they show how organs and tissues function in the body, in contrast to MRI or CT scans, which mostly show anatomy. Using radioactive tracers that produce a signal from within the body, PET scanners produce a 3D image that is constructed by computers using sophisticated mathematical techniques.

Related Links:

Western University
University Hospital of Liège



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.